Eve Biotek Ltd

Eve Biotek Ltd, based in Warrington, UK, is a small, active company founded five years ago. With four employees and £17,089 in assets, it operates from a virtual address—a point of concern as 137 companies share the same location. The company is led by four directors and two owners, and has a real trading status. It’s an irregular importer, primarily dealing in machinery, boilers, and mechanical appliances, with its last import activity recorded one month ago.

The company's website paints a picture of a global consultancy and CRO specializing in computational drug research and development. They offer bespoke services supported by innovative technology, aiming to accelerate drug development for their clients. Key personnel include Nils A Berglund (CEO), Martin B Ulmschneider (Chief Scientific Officer), Ayesha Khan (Business Development Director), and a team of scientists. The website emphasizes in silico testing expertise and encourages potential clients to contact them for more information.

Financially, Eve Biotek Ltd shows some interesting trends. While cash bank on hand increased significantly by 180%, reaching £17,000, other creditors rose sharply by 220%, reaching £11,000. Accumulated depreciation impairment property plant equipment increased by 150%, indicating investment in equipment. Net current assets liabilities increased by 120%, which could be a sign of increased operational expenses. The company’s small size (meeting two of three conditions for turnover under £10.2m, assets under £5.1m, and fewer than 50 employees) allows for flexibility, but the rise in creditors needs to be monitored. As a small company, it is exempt from an audit, so the figures are unaudited. It seems like the company is investing in its operations, but whether this will translate into profitability remains to be seen.

Registered in England/Wales under the registration number 12171618, with a registered address at WA1 1DN, England, Warrington, Trimble House, 9 Bold Street.

WARNING:The numbers have been rounded for simplicity and may be inaccurate.Please, refer to the latest financial report for verification.